Cited by 572Effects and risks of endocrine disrupting chemicalsToxic Organic Pollutants ImpactHealth, Environment, Cognitive Aging

Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06

Open access
Melzer, David, Rice, Neil E., Lewis, Ceri, Henley, William E., Galloway, Tamara S.·2010·PLoS ONE

Abstract

BACKGROUND: Bisphenol A (BPA) is a high production volume chemical widely used in food and drinks packaging. Associations have previously been reported between urinary BPA concentrations and heart disease, diabetes and liver enzymes in adult participants of the National Health and Nutrition Examination Survey (NHANES) 2003/04. We aimed to estimate associations between urinary BPA concentrations and health measures in NHANES 2005/06 and in data pooled across collection years. METHODOLOGY AND FINDINGS: A cross-sectional analysis of NHANES: subjects were n = 1455 (2003/04) and n = 1493 (2005/06) adults aged 18-74 years, representative of the general adult population of the United States. Regression models were adjusted for age, sex, race/ethnicity, education, income, smoking, BMI, waist circumference, and urinary creatinine concentration. Main outcomes were reported diagnoses of heart attack, coronary heart disease, angina and diabetes and serum liver enzyme levels. Urinary BPA concentrations in 2005/06 (geometric mean 1.79 ng/ml, 95% CI: 1.64 to 1.96) were lower than in 2003/04 (2.49 ng/ml, CI: 2.20 to 2.83, difference p-value = 0.00002). Higher BPA concentrations were associated with coronary heart disease in 2005/06 (OR per z-score increase in BPA = 1.33, 95%CI: 1.01 to 1.75, p = 0.043) and in pooled data (OR = 1.42, CI: 1.17 to 1.72, p = 0.001). Associations with diabetes did not reach significance in 2005/06, but pooled estimates remained significant (OR = 1.24, CI: 1.10 to 1.40, p = 0.001). There was no overall association with gamma glutamyl transferase concentrations, but pooled associations with alkaline phosphatase and lactate dehydrogenase remained significant. CONCLUSIONS: Higher BPA exposure, reflected in higher urinary concentrations of BPA, is consistently associated with reported heart disease in the general adult population of the USA. Studies to clarify the mechanisms of these associations are urgently needed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0008673

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • BPA may cause homeostatic disruptions including cardiovascular effects and hypertension, and by extension other EDCs may do so.

    “This would suggest an avenue for homeostatic disruptions including cardiovascular effects and hypertension associated with BPA and, by extension, other EDCs (142, 143).”

    From Endocrine Disruption of Vasopressin Systems and Related Behaviors (2017) · cites this paper as [143]

    The Discussion (page unavailable) reports an association between urinary BPA and heart disease and considers possible cardiovascular mechanisms, while cautioning that the cross-sectional findings do not establish causation. It links hypertension to lead, not BPA; its discussion of other contaminants does not establish that other endocrine-disrupting chemicals share BPA’s effects. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 47

  1. [1]Talsness CE Andrade AJM Kuriyama SN Taylor JA vom Saal FS 2009 Components of plastic: experimental studies in animals and relevance for human health. Philosophical Transactions of the Royal Society B-Biological Sciences 364 2079 2096 PMC2873015 19528057
  2. [3]Stahlhut RW Welshons WV Swan SH 2009 Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environmental Health Perspectives 117 784 789 19479022 PMC2685842
  3. [4]Calafat AM Kuklenyik Z Reidy JA Caudill SP Ekong J 2005 Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environmental Health Perspectives 113 391 395 15811827 PMC1278476
  4. [6]Vandenberg LN Hauser R Marcus M Olea N Welshons WV 2007 Human exposure to bisphenol A (BPA). Reproductive Toxicology 24 139 177 17825522
  5. [7]Wozniak AL Bulayeva NN Watson CS 2005 Xenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-alpha-mediated Ca2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environmental Health Perspectives 113 431 439 15811834 PMC1278483
  6. [8]Lee HJ Chattopadhyay S Gong EY Ahn RS Lee K 2003 Antiandrogenic effects of bisphenol A and nonylphenol on the function of androgen receptor. Toxicological Sciences 75 40 46 12805653
  7. [9]Okada H Tokunaga T Liu XH Takayanagi S Matsushima A 2008 Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma. Environmental Health Perspectives 116 32 38 18197296 PMC2199305
  8. [10]Bindhumol V Chitra KC Mathur PP 2003 Bisphenol A induces reactive oxygen species generation in the liver of male rats. Toxicology 188 117 124 12767684
  9. [11]Elsby R Maggs JL Ashby J Park BK 2001 Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: Implications for extrapolation to humans. Journal of Pharmacology and Experimental Therapeutics 297 103 113 11259533
  10. [12]Nakagawa Y Tayama S 2000 Metabolism and cytotoxicity of bisphenol A and other bisphenols in isolated rat hepatocytes. Archives of Toxicology 74 99 105 10839477
  11. [13]Roy D Palangat M Chen CW Thomas RD Colerangle J 1997 Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals. Journal of Toxicology and Environmental Health 50 1 29 9015129
  12. [14]Tyl RW Myers CB Marr MC Thomas BF Keimowitz AR 2002 Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicological Sciences 68 121 146 12075117
  13. [15]Ropero AB Alonso-Magdalena P Garcia-Garcia E Ripoll C Fuentes E 2008 Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. International Journal of Andrology 31 194 199 17971160
  14. [17]Newbold RR Padilla-Banks E Jefferson WN Heindel JJ 2008 Effects of endocrine disruptors on obesity. International Journal of Andrology 31 201 207 18315718
  15. [18]Goodman JE McConnell EE Sipes IG Witorsch RJ Slayton TM 2006 An updated weight of the evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. Critical Reviews in Toxicology 36 387 457 16954066
  16. [20]vom Saal FS Akingbemi BT Belcher SM Birnbaum LS Crain DA 2007 Chapel Hill bisphenol A expert panel consensus statement: Integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reproductive Toxicology 24 131 138 17768031 PMC2967230
  17. [21]Welshons WV Nagel SC vom Saal FSV 2006 Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147 S56 S69 16690810
  18. [22]Volkel W Colnot T Csanady GA Filser JG Dekant W 2002 Metabolism and kinetics of bisphenol A in humans at low doses following oral administration. Chem Res Toxicol 15 1281 1287 12387626
  19. [23]Lang IA Galloway TS Scarlett A Henley WE Depledge M 2008 Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. Journal of the American Medical Association 300 1303 1310 18799442
  20. [24]Melzer D Lang IA Galloway TS 2009 Association of bisphenol A with diabetes and other abnormalities reply. Journal of the American Medical Association 301 721 722
  21. [27]Barr DB Wilder LC Caudill SP Gonzalez AJ Needham LL 2005 Urinary creatinine concentrations in the US population: Implications for urinary biologic monitoring measurements. Environmental Health Perspectives 113 192 200 15687057 PMC1277864
  22. [28]Wood SN 2006 On confidence intervals for generalized additive models based on penalized regression splines. Australian & New Zealand Journal of Statistics 48 445 464
  23. [29]Hsieh FY Bloch DA Larsen MD 1998 A simple method of sample size calculation for linear and logistic regression. Statistics in Medicine 17 1623 1634 9699234
  24. [30]Katsouyanni K Touloumi G Samoli E Gryparis A Le Tertre A 2001 Confounding and effect modification in the short-term effects of ambient particles on total mortality: Results from 29 European cities within the APHEA2 project. Epidemiology 12 521 531 11505171
  25. [31]Samet JM Dominici F Curriero FC Coursac I Zeger SL 2000 Fine particulate air pollution and mortality in 20 US Cities, 1987–1994. New England Journal of Medicine 343 1742 1749 11114312
  26. [32]Peters A Frohlich M Doring A Immervoll T Wichmann HE 2001 Particulate air pollution is associated with an acute phase response in men - Results from the MONICA-Augsburg Study. European Heart Journal 22 1198 1204 11440492
  27. [33]Grun F Blumberg B 2007 Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Reviews in Endocrine & Metabolic Disorders 8 161 171 17657605
  28. [34]Mills NL Tornqvist H Robinson SD Gonzalez M Darnley K 2005 Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation 112 3930 3936 16365212
  29. [35]Nemmar A Hoet PHM Dinsdale D Vermylen J Hoylaerts MF 2003 Diesel exhaust particles in lung acutely enhance experimental peripheral thrombosis. Circulation 107 1202 1208 12615802
  30. [36]Suwa T Hogg JC Quinlan KB Ohgami A Vincent R 2002 Particulate air pollution induces progression of atherosclerosis. Journal of the American College of Cardiology 39 935 942 11897432
  31. [37]Simeonova PP Luster MI 2004 Arsenic and atherosclerosis. Toxicology and Applied Pharmacology 198 444 449 15276425
  32. [38]Wang CH Jeng JS Yip PK Chen CL Hsu LI 2002 Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 105 1804 1809 11956123
  33. [39]Drobna Z Jaspers I Thomas DJ Styblo M 2003 Differential activation of AP-1 in human bladder epithelial cells by inorganic and methylated arsenicals. FASEB Journal 17 67 69 12475910
  34. [40]Martin D Glass TA Bandeen-Roche K Todd AC Shi WP 2006 Association of blood lead and tibia lead with blood pressure and hypertension in a community sample of older adults. American Journal of Epidemiology 163 467 478 16421242
  35. [41]Hennig B Hammock BD Slim R Toborek M Saraswathi V 2002 PCB-induced oxidative stress in endothelial cells: modulation by nutrients. International Journal of Hygiene and Environmental Health 205 95 102 12018021
  36. [42]Stegeman JJ Hahn ME Weisbrod R Woodin BR Joy JS 1995 Induction of Cytochrome P4501a1 by Aryl-Hydrocarbon Receptor Agonists in Porcine Aorta Endothelial-Cells in Culture and Cytochrome P4501a1 Activity in Intact-Cells. Molecular Pharmacology 47 296 306 7870038
  37. [43]Bombick DW Matsumura F Madhukar BV 1984 TCDD (2,3,7,8-tetrachlorodibenzo-para-dioxin) causes reduction in the low-density lipoprotein (LDL) receptor activities in the hepatic plasma-membrane of the guinea-pig and rat. Biochemical and Biophysical Research Communications 118 548 554 6322751
  38. [44]Lovati MR Galbussera M Franceschini G Weber G Resi L 1984 Increased plasma and aortic triglycerides in rabbits after acute administration of 2,3,7,8-tetrachlorodibenzo-para-dioxin. Toxicology and Applied Pharmacology 75 91 97 6464024
  39. [45]Mahadik SR Deo SS Mehtalia SD 2008 Association of adiposity, inflammation and atherosclerosis: The role of adipocytokines and CRP in Asian Indian subjects. Metabolic Syndrome and Related Disorders 6 121 128 18484906
  40. [46]Teeguarden JG Waechter JM Clewell HJ Covington TR Barton HA 2005 Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: A physiologically based pharmacokinetic approach. Toxicological Sciences 85 823 838 15746009
  41. [47]Hong YC Park EY Park MS Ko JA Oh SY 2009 Community level exposure to chemicals and oxidative stress in adult population. Toxicology Letters 184 139 144 19049859
  42. [48]Yang YJ Hong YC Oh SY Park MS Kim H 2009 Bisphenol A exposure is associated with oxidative stress and inflammation in postmenopausal women. Environmental Research 109 797 801 19464675
  43. [49]Wada K Sakamoto H Nishikawa K Sakuma S Nakajima A 2007 Life style-related diseases of the digestive system: Endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome. Journal of Pharmacological Sciences 105 133 137 17928741
  44. [50]Alonso-Magdalena P Morimoto S Ripoll C Fuentes E Nadal A 2006 The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environmental Health Perspectives 114 106 112 PMC1332664 16393666
  45. [51]Vasiliu O Cameron L Gardiner J DeGuire P Karmaus W 2006 Polybrominated biphenyls, polychlorinated biphenyls, body weight, and incidence of adult-onset diabetes mellitus. Epidemiology 17 352 359 16755267
  46. [53]Eto K Ohya Y Nakamura Y Abe I Fujishima M 2001 Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle. European Journal of Pharmacology 423 1 7 11438300
  47. [54]Wright HM Clish CB Mikami T Hauser S Yanagi K 2000 A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation. Journal of Biological Chemistry 275 1873 1877 10636887

Cited by

Sorted by citations

Authors
Melzer, D., Rice, N. E., Lewis, C., Henley, W. E., & Galloway, T. S.
Affiliations
  • University of Exeter (GB)
  • University of Plymouth (GB)
Corresponding author
Melzer, David
Venue
PLoS ONE
Published
2010-01-13
Volume
5
Issue
1
Pages
e8673
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2088514819
Cited by
572
References
3
Citations by year
2026: 7 · 2025: 23 · 2024: 29 · 2023: 28 · 2022: 36 · 2021: 26 · 2020: 32 · 2019: 31 · 2018: 42 · 2017: 42 · 2016: 48 · 2015: 44 · 2014: 39 · 2013: 46 · 2012: 46
FWCI
35.51
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion)
  • Open Research Exeter (University of Exeter) (submittedVersion)
Topics
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Health, Environment, Cognitive Aging
Keywords
bisphenol A, coronary artery disease, myocardial infarction, angina pectoris, diabetes mellitus, liver enzymes, gamma-glutamyl transferase, alkaline phosphatase, lactate dehydrogenase, endocrine disruptors, NHANES, biomonitoring, cardiovascular risk
MeSH terms
Bisphenol A Compounds, Benzhydryl Compounds, Cross-Sectional Studies, Heart Diseases, Humans, Nutrition Surveys, Phenols

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review